“obeticholic-acid” Archives

in
Entry Author Date Location
Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries 10/01/20 Europe
Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25% 09/01/20 New York
FDA Lifts CymaBay Drug Hold, Tests to Resume in Rare Liver Disease PBC 07/23/20 San Francisco
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
Enanta Steps Forward in NASH Race, With Unclear Prospects 09/26/19 Boston
CymaBay Therapeutics Stumbles in NASH Race, Shares Fall 06/11/19 San Francisco
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
With New Data, Intercept On Track for First-Ever Approved NASH Drug 02/19/19 New York
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease 05/28/16 New York
East Coast Biotech Roundup: PfizerGan, Nimbus, Intercept, Tesaro & More 04/08/16 Boston
Advisory Panel Backs Intercept’s Liver Drug, FDA Ruling up Next 04/07/16 New York
West Coast Bio Roundup: Pfizer’s BBC Ghosts, Gilead’s NASH, HLI’s Cash 04/07/16 San Francisco
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test 03/18/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Intercept Ends Roller Coaster Weekend With Phase 3 Victory 03/16/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Retrophin Shares Boom Following Manchester Pharma Buyout 02/13/14 New York
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Intercept Shares Skyrocket After Liver Drug Nails Mid-Stage Study 01/09/14 New York
Page 1 of 1